Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 10,613	$ 264,538
Prepaid expenses	15,143	0
Cash and marketable securities held in Trust Account	0	29,728,990
Total Current Assets	25,756	29,993,528
Cash held in Trust Account	7,508,088	7,372,451
TOTAL ASSETS	7,533,844	37,365,979
Current liabilities
Accounts payable and accrued expenses	1,360,707	469,268
Excise tax payable	3,062,004	3,062,004
Accrued offering costs	5,000	5,000
Income taxes payable	312,334	308,194
Common stock to be redeemed (2,768,301 shares of Series A common stock)	0	29,728,990
Total Current Liabilities	6,605,045	35,388,456
Deferred underwriting fee payable	10,500,000	10,500,000
Total Liabilities	17,105,045	45,888,456
Commitments (Note 6)
Series A common stock subject to possible redemption; 667,391 shares issued and outstanding at March 31, 2024 and December 31, 2023 at redemption value of $11.11 and $10.93 per share, respectively	7,413,838	7,292,641
Stockholders' Deficit
Preferred stock, $0.0001 par value; 1,000,000 shares authorized, none issued and outstanding	0	0
Additional paid-in capital	0	0
Accumulated deficit	(16,985,789)	(15,815,868)
Total Stockholders' Deficit	(16,985,039)	(15,815,118)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	7,533,844	37,365,979
Related party [Member]
Current liabilities
Extension promissory note - related party	160,000	160,000
Advance from related parties	1,705,000	1,655,000
Series A common stock [Member]
Current liabilities
Common stock to be redeemed (2,768,301 shares of Series A common stock)		29,728,990
Stockholders' Deficit
Common Stock	749	749
Series B common stock [Member]
Stockholders' Deficit
Common Stock	$ 1	$ 1